STAT+: Pharmalittle: U.S. sits on millions of AstraZeneca vaccine doses; WTO again fails to act on Covid-19 proposal
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is optimistic. We hope to check in on the Pharmalot ancestors, promenade with the official mascot, and catch up on our reading. Or maybe take a few naps. And what about you? This may be a good time to enjoy the great outdoors and get some fresh air. You could help the economy by placing an order with a local eatery. Or check in on someone who has felt isolated this past year. On that note, you may want to check the wait list for vaccines. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon …
Tens of millions of doses of the Covid-19 vaccine made by AstraZeneca (AZN) are sitting idly in American manufacturing facilities, awaiting results from its U.S. clinical trial while countries that have authorized its use beg for access, The New York Times reports. The fate of those doses is the subject of an intense debate among White House and federal health officials, with some arguing the administration should let them go abroad where they are desperately needed while others are not ready to relinquish them. AstraZeneca is involved in the talks.
Continue to STAT+ to read the full story…
